Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Protagonist Therapeutics, Inc.

PTGX Technical Analysis Summary (NASDAQ)

Analyze PTGX on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.

PTGX●NASDAQ
HealthcareBiotechnology
$143.46
$4.32(2.92%)
U.S. Market is Open · 13:36

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

PTGX Technical Analysis Summary (NASDAQ)

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 46.00)
Trend Strength:Weak (ADX: 18.83)
Volatility:Medium (ATR: 5.54)
Support/Resistance:$141.26 – $156.62 (Bollinger Bands)

Technical conditions suggest Protagonist Therapeutics, Inc. on the NASDAQ is awaiting a decisive move. This mix signals that Protagonist Therapeutics, Inc. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 46.00

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 31.29

Bearish
Momentum remains weak below midpoint.

Williams %R: -81.13

Bullish
Oversold zone suggests rebound potential.

Rate of Change (ROC): -4.47

Bearish
Selling pressure outweighs buying.

Takeaway:Protagonist Therapeutics, Inc. shows strong bearish momentum, signaling downside pressure.

Trend & Volatility

MACD: 0.48

Bullish
Bullish, trend momentum is strengthening.

ADX: 18.83

Weak
Weak trend, market trading sideways.

ATR (14): 5.54

High
High volatility, wide price fluctuations.

CCI (14): -106.70

Bearish
Bearish, oversold conditions may spark rebound.

Takeaway:Protagonist Therapeutics, Inc. shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$156.62
Middle Band (SMA 20)
$148.94
Lower Band
$141.26
Current Position
Within Bands

Takeaway:Protagonist Therapeutics, Inc. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$158.00
Middle Line (EMA 20)
$146.93
Lower Channel
$135.86
Squeeze Status
Squeeze On

Takeaway:Protagonist Therapeutics, Inc. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume42.23K
Money Flow Index44.61Neutral, balanced money flows with no clear signal.
Relative Vigor Index42.33Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:PTGX shows balanced money flow with a slight bearish tilt.

Technical Trading Signals Summary
Based on the current technical analysis of Protagonist Therapeutics, Inc. (NASDAQ: PTGX), here are the key trading signals and recommendations:

Bullish Signals

MACD above 0 → bullish trend confirmation.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Protagonist Therapeutics, Inc. are mixed, suggesting a Hold or wait-and-see approach.

(NASDAQ: PTGX) Technical Analysis FAQ